RxDoctor Payments Data

Lee Ellender, MD

Family Medicine · Opelousas, LANPI 1558364331

Payments from drug & device makers

$396in general payments, 2019–2025

Across 26 payments — averaging $15.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$216
  • Lilly USA, LLC$59
  • Amgen$31
  • Exact Sciences$20
  • AbbVie$18
  • Novartis$15
  • plus $38 from 3 others

What the payments were for

  • Food & beverage$396100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$396 in reported general payments places this provider in the 40th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$193,469
Medicare patients
151
Services billed
4,249

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide60$74,688
OzempicSemaglutide31$32,882
JanuviaSitagliptin Phosphate30$31,181
EliquisApixaban29$22,380
Spiriva HandihalerTiotropium Bromide13$7,659
LinzessLinaclotide11$6,788
XareltoRivaroxaban12$5,479
Valsartan123$3,762
Pantoprazole Sodium284$3,723
Hydralazine Hcl205$3,702
Clonidine19$3,480
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$3,282
Novolin 70-30 FlexpenInsulin Nph Hum/Reg Insulin Hm26$2,836
Amlodipine Besylate474$2,649
Rosuvastatin Calcium242$2,554

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Humulin 70-30$59$75,68271 claims
Novo NordiskOzempic$216$32,88231 claims
MerckJanuvia$11$31,18130 claims
AbbVieLinzess, Synthroid$18$8,36833 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 1,469 family medicine providers in Louisiana.

Other family medicine in Opelousas

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →